Semaglutide Side Effects: What to Expect & How to Manage Them
Semaglutide is the active molecule in Ozempic, Wegovy, and compounded weight-loss programs. Most people tolerate it, but nearly everyone feels some gastrointestinal effects early on. Here's exactly what to expect, what's serious, and how to minimize it.
Quick Answer: What Are the Side Effects of Semaglutide?
The most common semaglutide side effects are gastrointestinal — nausea (~44%), diarrhea (~30%), vomiting (~25%), and constipation (~23%) — reported in the STEP-1 trial (Wegovy, semaglutide 2.4 mg; New England Journal of Medicine, 2021). They are usually mild to moderate, are worst in the first few weeks and after each dose increase, and fade as your body adjusts. Serious but rare risks include pancreatitis and gallbladder problems. The single biggest lever for tolerating semaglutide is a slow titration schedule — starting low and increasing gradually — which is why the provider you choose matters.
Reviewed by Dr. A. Goher, MD. Prevalence figures are from the STEP-1 trial and the FDA-approved prescribing information for semaglutide 2.4 mg. This is general information, not medical advice.
Common Semaglutide Side Effects (and How Often)
| Side effect | How common | What to know |
|---|---|---|
| Nausea | ~44% | Most common; worst in the first weeks and after each dose increase. |
| Diarrhea | ~30% | Usually mild; stay hydrated. |
| Vomiting | ~25% | More likely at higher doses or if you eat past fullness. |
| Constipation | ~23% | Fiber and water help; can alternate with diarrhea. |
| Abdominal pain | ~20% | Cramping/bloating; persistent severe pain needs a doctor. |
| Headache / fatigue | ~11–14% | Often tied to lower food/fluid intake early on. |
Source: STEP-1 (semaglutide 2.4 mg, NEJM, 2021) and the FDA prescribing information. Compounded semaglutide uses the same molecule, so the side-effect profile is the same at an equivalent dose.
Serious Semaglutide Side Effects — When to Call a Doctor
These are rare, but you should stop and contact a clinician (or seek urgent care) if you experience them:
- Pancreatitis — severe, persistent abdominal pain that may radiate to the back, often with vomiting. Stop semaglutide and get evaluated.
- Gallbladder problems — pain in the upper-right abdomen, fever, or yellowing skin; gallstones are a known risk with rapid weight loss.
- Severe dehydration / kidney injury — from prolonged vomiting or diarrhea; a real risk if you can't keep fluids down.
- Allergic reaction — rash, swelling, or trouble breathing.
- Vision changes — the FDA label notes a risk of worsening diabetic retinopathy in people with type 2 diabetes.
Semaglutide carries an FDA boxed warning for a risk of thyroid C-cell tumors based on rodent studies; it is not prescribed to people with a personal or family history of medullary thyroid carcinoma or MEN 2. This is on the FDA-approved label — a licensed clinician screens for it before prescribing.
How to Minimize Semaglutide Side Effects
- Titrate slowly. Most side effects come from going up in dose too fast. A good provider starts at 0.25 mg and increases only when you're tolerating the current dose.
- Eat smaller, slower meals. Semaglutide slows stomach emptying — eating past fullness is the fastest route to nausea and vomiting.
- Hydrate and add fiber. This blunts both constipation and the fatigue that comes with eating less.
- Avoid greasy, heavy, or very sweet foods early on, and limit alcohol.
- Tell your prescriber if a dose is intolerable — holding or stepping back a dose is normal and usually fixes it.
Because titration is the biggest factor, the provider matters: choose one with real clinician oversight and a proper step-up schedule, not a one-size-fits-all auto-escalation. See our best GLP-1 providers ranking (all offer clinician-managed titration), or compare by price on the cheapest ranking.
Semaglutide vs. Tirzepatide Side Effects
Both are GLP-1 medications with a similar gastrointestinal side-effect profile. Tirzepatide (Zepbound/Mounjaro) is a dual GIP/GLP-1 agonist and produces more weight loss (~21% in SURMOUNT-1 vs ~15% for semaglutide in STEP-1), with broadly comparable GI side effects at effective doses. Which is better tolerated varies by person — see semaglutide vs tirzepatide for the full comparison.
Semaglutide Side Effects — FAQ
What are the side effects of semaglutide?
The most common semaglutide side effects are gastrointestinal: nausea (~44%), diarrhea (~30%), vomiting (~25%), constipation (~23%), and abdominal pain (~20%), based on the STEP-1 trial. They are usually mild to moderate, worst in the first weeks and after dose increases, and fade over time. Rare serious risks include pancreatitis and gallbladder problems.
How long do semaglutide side effects last?
For most people, nausea and other GI side effects are worst in the first 1–4 weeks and after each dose increase, then ease as the body adjusts — often settling within 4–8 weeks at a stable dose. Titrating slowly shortens and softens this period.
Is semaglutide safe?
Semaglutide is FDA-approved and, for most people, well tolerated under clinician supervision. It carries a boxed warning for a theoretical thyroid tumor risk (from rodent studies) and isn't used in people with a history of medullary thyroid cancer or MEN 2. A licensed provider screens for contraindications before prescribing.
How do I stop semaglutide nausea?
Eat smaller, slower meals and stop at the first sign of fullness, stay hydrated, avoid greasy or very sweet foods and alcohol, and don't increase your dose until you're tolerating the current one. If nausea is severe or you can't keep fluids down, contact your prescriber — holding or lowering the dose usually resolves it.